Status:
COMPLETED
Tobramycin-Dexamethasone Versus Tobramycin-Dexamethasone Plus Ketorolac After Phacoemulsification Surgery
Lead Sponsor:
Veroia General Hospital
Conditions:
Cataract
Eligibility:
All Genders
55-95 years
Phase:
NA
Brief Summary
This randomized controlled trial compares two regimens of topical therapy: * tobramycin 0.3% - dexamethasone 0.1% (TobraDex®, Alcon), one drop four times/day * combination of tobramycin 0.3% - dexame...
Eligibility Criteria
Inclusion
- Phacoemulsification (due to cataract)
- Uneventful phacoemulsification surgery
Exclusion
- Disruption of the anterior lens capsule
- Age-related macular degeneration
- Proliferative diabetic retinopathy
- Glaucoma
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00992355
Start Date
January 1 2009
End Date
April 1 2009
Last Update
October 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Veroia General Hospital
Véroia, Greece, 59100